1195306

Acrotech Biopharma Inc. — FEI 3015381658

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 19, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
East Windsor, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
673521 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
683521 CFR 314.80(d)Failure to submit scientific article